• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋球菌疫苗的最新研究进展

Recent Progress Towards a Gonococcal Vaccine.

机构信息

Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States.

出版信息

Front Cell Infect Microbiol. 2022 Apr 11;12:881392. doi: 10.3389/fcimb.2022.881392. eCollection 2022.

DOI:10.3389/fcimb.2022.881392
PMID:35480233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9038166/
Abstract

Gonorrhea is a global health concern. Its etiological agent, , rapidly acquires antimicrobial resistance and does not confer protective immunity as a consequence of infection. Attempts to generate an effective vaccine for gonorrhea have thus far been unsuccessful, as many structures on the bacterial envelope have the propensity to rapidly change, thus complicating recognition by the human immune system. In response to recent efforts from global health authorities to spur the efforts towards development of a vaccine, several new and promising steps have been made towards this goal, aided by advancements in computational epitope identification and prediction methods. Here, we provide a short review of recent progress towards a viable gonococcal vaccine, with a focus on antigen identification and characterization, and discuss a few of the tools that may be important in furthering these efforts.

摘要

淋病是一个全球性的健康问题。其病原体 ,迅速获得抗微生物药物耐药性,并且由于感染而不能产生保护性免疫。因此,迄今为止,试图为淋病生成有效的疫苗一直未能成功,因为细菌包膜上的许多结构都有迅速改变的倾向,从而使人类免疫系统难以识别。为了应对全球卫生当局最近为推动疫苗开发所做的努力,在计算表位鉴定和预测方法的帮助下,在朝着这一目标取得了一些新的、有希望的进展。在这里,我们提供了一个关于可行的淋球菌疫苗的最新进展的简短综述,重点是抗原的鉴定和特性,并讨论了一些可能对推进这些努力很重要的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcb/9038166/b396bf51b60b/fcimb-12-881392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcb/9038166/b396bf51b60b/fcimb-12-881392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcb/9038166/b396bf51b60b/fcimb-12-881392-g001.jpg

相似文献

1
Recent Progress Towards a Gonococcal Vaccine.淋球菌疫苗的最新研究进展
Front Cell Infect Microbiol. 2022 Apr 11;12:881392. doi: 10.3389/fcimb.2022.881392. eCollection 2022.
2
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.淋病奈瑟菌同源物与 B 群脑膜炎奈瑟球菌外膜蛋白的遗传相似性。
mBio. 2019 Sep 10;10(5):e01668-19. doi: 10.1128/mBio.01668-19.
3
Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.淋病奈瑟菌候选疫苗变异性的综合生物信息学评估。
mSphere. 2021 Feb 3;6(1):e00977-20. doi: 10.1128/mSphere.00977-20.
4
Immune responses to and implications for vaccine development.针对 的免疫反应及其对疫苗开发的意义。
Front Immunol. 2023 Aug 17;14:1248613. doi: 10.3389/fimmu.2023.1248613. eCollection 2023.
5
Progress Toward a Gonococcal Vaccine: The Way Forward.迈向淋球菌疫苗的进展:前进之路。
Front Immunol. 2019 Oct 15;10:2417. doi: 10.3389/fimmu.2019.02417. eCollection 2019.
6
Neisseria gonorrhoeae vaccine development: hope on the horizon?淋病奈瑟菌疫苗的研发:曙光在前?
Curr Opin Infect Dis. 2018 Jun;31(3):246-250. doi: 10.1097/QCO.0000000000000450.
7
Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.微囊化的白细胞介素-12 驱动生殖道对鼻内淋球菌外膜囊泡疫苗的免疫反应,并诱导对多种淋病奈瑟菌菌株阴道感染的抵抗力。
mSphere. 2023 Feb 21;8(1):e0038822. doi: 10.1128/msphere.00388-22. Epub 2022 Dec 20.
8
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.脂寡糖肽模拟候选淋病球菌疫苗的临床前疗效。
mBio. 2019 Nov 5;10(6):e02552-19. doi: 10.1128/mBio.02552-19.
9
A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection Among Urban Men Who Have Sex With Men.淋病球菌疫苗有可能迅速降低城市男男性行为者中淋病奈瑟菌感染的发生率。
J Infect Dis. 2022 Mar 15;225(6):983-993. doi: 10.1093/infdis/jiab581.
10
Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.淋球菌病可以预防吗?了解免疫和发病机制在疫苗研发中的重要性。
Crit Rev Microbiol. 2016 Nov;42(6):928-41. doi: 10.3109/1040841X.2015.1105782. Epub 2016 Jan 23.

引用本文的文献

1
Transcriptional responses of to glucose and lactate: implications for resistance to oxidative damage and biofilm formation.对葡萄糖和乳酸的转录反应:对氧化损伤和生物膜形成的抗性的影响。
mBio. 2024 Aug 14;15(8):e0176124. doi: 10.1128/mbio.01761-24. Epub 2024 Jul 16.
2
Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.迫切需要了解和预防淋病奈瑟菌感染:从实验室到真实世界的情况。
J Infect Dis. 2024 Oct 16;230(4):e758-e767. doi: 10.1093/infdis/jiae289.
3
Addressing Sexually Transmitted Infections Due to in the Present and Future.

本文引用的文献

1
Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis.基于微粒的细菌外膜囊泡(OMVs)疫苗平台在性传播疾病(STD)中的潜在应用:淋病、衣原体感染和梅毒。
Vaccines (Basel). 2021 Oct 27;9(11):1245. doi: 10.3390/vaccines9111245.
2
Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.脑膜炎球菌解毒外膜囊泡疫苗增强了小鼠感染模型中淋球菌的清除。
J Infect Dis. 2022 Feb 15;225(4):650-660. doi: 10.1093/infdis/jiab450.
3
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
应对当前及未来由……引起的性传播感染 。 你提供的原文中“due to”后面似乎缺失了具体内容。
Microorganisms. 2024 Apr 28;12(5):884. doi: 10.3390/microorganisms12050884.
4
Role of Extracellular Vesicles in Immunity and Host Defense.细胞外囊泡在免疫和宿主防御中的作用。
Immunol Invest. 2024 Jan;53(1):10-25. doi: 10.1080/08820139.2024.2312896. Epub 2024 Feb 13.
5
2023 Korean Association of Urogenital Tract Infection and Inflammation guidelines for gonococcal infection.2023 年韩国泌尿生殖系感染和炎症协会淋球菌感染指南。
Investig Clin Urol. 2024 Jan;65(1):1-8. doi: 10.4111/icu.20230265.
6
Quantitative assessment of multiple pathogen exposure and immune dynamics at scale.大规模量化评估多种病原体暴露和免疫动力学。
Microbiol Spectr. 2024 Jan 11;12(1):e0239923. doi: 10.1128/spectrum.02399-23. Epub 2023 Dec 8.
7
Promising developments in gonococcal vaccines.淋球菌疫苗的研究进展令人鼓舞。
Curr Opin Infect Dis. 2024 Feb 1;37(1):63-69. doi: 10.1097/QCO.0000000000000992. Epub 2023 Dec 4.
8
Evaluating vaccine-elicited antibody activities against : cross-protective responses elicited by the 4CMenB meningococcal vaccine.评估疫苗诱导的抗体活性针对:4CMenB 脑膜炎球菌疫苗诱导的交叉保护反应。
Infect Immun. 2023 Dec 12;91(12):e0030923. doi: 10.1128/iai.00309-23. Epub 2023 Nov 22.
9
Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved SliC antigen that blocks human lysozyme.开发一种标签/捕获介导的衣壳病毒样颗粒疫苗,展示保守的 SliC 抗原,该抗原可阻断人溶菌酶。
Infect Immun. 2023 Dec 12;91(12):e0024523. doi: 10.1128/iai.00245-23. Epub 2023 Nov 2.
10
Emerging threat of antimicrobial resistance in Neisseria gonorrhoeae: pathogenesis, treatment challenges, and potential for vaccine development.淋病奈瑟菌中抗菌药物耐药性的新出现威胁:发病机制、治疗挑战和疫苗开发的潜力。
Arch Microbiol. 2023 Sep 9;205(10):330. doi: 10.1007/s00203-023-03663-0.
基于 B 群脑膜炎奈瑟菌外膜囊泡的疫苗 4CMenB 可诱导针对淋病奈瑟菌的种间保护。
PLoS Pathog. 2020 Dec 8;16(12):e1008602. doi: 10.1371/journal.ppat.1008602. eCollection 2020 Dec.
4
Enhancement of immune responses by co-administration of bacterial ghosts-mediated Neisseria gonorrhoeae DNA vaccines.细菌体介导淋病奈瑟菌 DNA 疫苗联合给药增强免疫应答。
J Appl Microbiol. 2021 May;130(5):1770-1777. doi: 10.1111/jam.14815. Epub 2020 Nov 6.
5
Molecular Insight into TdfH-Mediated Zinc Piracy from Human Calprotectin by Neisseria gonorrhoeae.淋病奈瑟菌通过 TdfH 介导从人钙卫蛋白中窃取锌的分子洞察。
mBio. 2020 May 26;11(3):e00949-20. doi: 10.1128/mBio.00949-20.
6
The Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells.候选疫苗NHBA可诱导产生具有杀菌、调理吞噬作用以及能降低淋球菌对上皮细胞黏附性的抗体。
Vaccines (Basel). 2020 May 13;8(2):219. doi: 10.3390/vaccines8020219.
7
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.淋球菌疫苗:公共卫生价值和首选产品特征;世卫组织全球利益攸关方协商会议报告,2019 年 1 月。
Vaccine. 2020 Jun 9;38(28):4362-4373. doi: 10.1016/j.vaccine.2020.02.073. Epub 2020 Apr 28.
8
Structural Basis for Evasion of Nutritional Immunity by the Pathogenic .病原体逃避营养免疫的结构基础
Front Microbiol. 2020 Jan 10;10:2981. doi: 10.3389/fmicb.2019.02981. eCollection 2019.
9
Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells.淋球菌肝素结合抗原在微菌落形成、血清抵抗和黏附上皮细胞中的作用。
J Infect Dis. 2020 Apr 27;221(10):1612-1622. doi: 10.1093/infdis/jiz628.
10
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.脂寡糖肽模拟候选淋病球菌疫苗的临床前疗效。
mBio. 2019 Nov 5;10(6):e02552-19. doi: 10.1128/mBio.02552-19.